[Clinical burden caused by hospitalization for febrile neutropenia in France in 2010-2011: An analysis of the PMSI database] |
journalArticle |
2016 |
Freyer, G.; Scotte, F.; Borget, I.; Bruyas, A.; Vainchtock, A.; Chouaid, C. |
Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study) |
journalArticle |
2017 |
Fresneau, Brice; Hackshaw, A.; Hawkins, D. S.; Paulussen, M.; Anderson, J. R.; Judson, I.; Litière, S.; Dirksen, U.; Lewis, I.; van den Berg, H.; Gaspar, N.; Gelderblom, H.; Whelan, J.; Boddy, A. V.; Wheatley, K.; Pignon, J. P.; De Vathaire, F.; Le Deley, M. C.; Le Teuff, G. |
Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study |
journalArticle |
2018 |
Fresneau, B.; Orbach, D.; Faure-Conter, C.; Sudour-Bonnange, H.; Vérité, C.; Gandemer, V.; Pasquet, M.; Fasola, S.; Rome, A.; Raimbault, S.; Martelli, H.; Frappaz, D.; Le Teuff, G.; Patte, C. |
Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes |
journalArticle |
2018 |
Frank, S. J.; Pugh, T. J.; Blanchard, P.; Mahmood, U.; Graber, W. J.; Kudchadker, R. J.; Davis, J. W.; Kim, J.; Choi, H.; Troncoso, P.; Kuban, D. A.; Choi, S.; McGuire, S.; Hoffman, K. E.; Chen, H. C.; Wang, X.; Swanson, D. A. |
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation |
journalArticle |
2018 |
Frank, S. J.; Blanchard, P.; Lee, J. J.; Sturgis, E. M.; Kies, M. S.; Machtay, M.; Vikram, B.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Fuller, C. D.; Hutcheson, K.; Lai, S.; Busse, P. M.; Lee, N. Y.; Lin, A.; Foote, R. L. |
Developmental predictors of inattention-hyperactivity from pregnancy to early childhood |
journalArticle |
2015 |
Foulon, S.; Pingault, J. B.; Larroque, B.; Melchior, M.; Falissard, B.; Cote, S. M. |
Predictors of Study Attrition in a Randomized Controlled Trial Evaluating a Perinatal Home-Visiting Program with Mothers with Psychosocial Vulnerabilities |
journalArticle |
2015 |
Foulon, S.; Greacen, T.; Pasquet, B.; Dugravier, R.; Saias, T.; Guedeney, N.; Guedeney, A.; Tubach, F.; Group, Capedp Study |
Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group |
journalArticle |
2016 |
Foulon, S.; Brennan, B.; Gaspar, N.; Dirksen, U.; Jeys, L.; Cassoni, A.; Claude, L.; Seddon, B.; Marec-Berard, P.; Whelan, J.; Paulussen, M.; Streitbuerger, A.; Oberlin, O.; Juergens, H.; Grimer, R.; Le Deley, M. C. |
Health state utility and quality of life measures in patients with chronic myeloid leukemia in France |
journalArticle |
2021 |
Foulon S, Cony-Makhoul P, Guerci-Bresler A, Daban M, Kapso R, Tubert-Bitter P, Bonastre J |
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy |
journalArticle |
2018 |
Ferrara, R.; Mezquita, L.; Texier, M.; Lahmar, J.; Audigier-Valette, C.; Tessonnier, L.; Mazieres, J.; Zalcman, G.; Brosseau, S.; Le Moulec, S.; Leroy, L.; Duchemann, B.; Lefebvre, C.; Veillon, R.; Westeel, V.; Koscielny, S.; Champiat, S.; Ferte, C.; Planchard, D.; Remon, J.; Boucher, M. E.; Gazzah, A.; Adam, J.; Bria, E.; Tortora, G.; Soria, J. C.; Besse, B.; Caramella, C. |
Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experience |
journalArticle |
2018 |
Fayard, F.; Petit, C.; Lacas, B.; Pignon, J. P. |
Meta-analysis of prognostic and predictive factors: Towards individual participant data? |
journalArticle |
2018 |
Faron, Matthieu; Pignon, Jean-Pierre; Paoletti, Xavier |
How to Reliably Assess Nodal Status in Distal Pancreatectomy for Adenocarcinoma |
journalArticle |
2018 |
Faron, M.; Vuarnesson, H.; Boher, J. M.; Bachellier, P.; Sauvanet, A.; Sa Cunha, A.; Le Treut, Y. P.; Mabrut, J. Y.; Delpero, J. R.; Paye, F. |
Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials |
journalArticle |
2015 |
Faron, M.; Pignon, J. P.; Malka, D.; Bourredjem, A.; Douillard, J. Y.; Adenis, A.; Elias, D.; Bouché, O.; Ducreux, M. |
Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials |
journalArticle |
2015 |
Faron, M.; Pignon, J. P.; Malka, D.; Bourredjem, A.; Douillard, J. Y.; Adenis, A.; Elias, D.; Bouché, O.; Ducreux, M. |
[Does sentinel lymph node identification has indication in digestive cancers?] |
journalArticle |
2019 |
Faron, M.; Laas, E. |
Compartmental resection of a retroperitoneal sarcoma |
journalArticle |
2019 |
Faron, M.; Cavalcanti, A.; Honore, C. |
Meta analyse des traitements néoadjuvants des cancers de l’œsophage et de la jonction oeso-gastrique |
thesis |
|
Faron Mathieu |
Biomarker Discovery and Validation: Statistical Considerations |
journalArticle |
2021 |
Fang-Shu Ou, PhD,a, Stefan Michiels, PhD,b Yu Shyr, PhD,c Alex A. Adjei, MD, PhD,d Ann L. Oberg, PhD |
Forget lung, breast or prostate cancer: why tumour naming needs to change |
journalArticle |
2024 |
Fabrice André, Elie Rassy, Aurélien Marabelle, Stefan Michiels & Benjamin Besse |
Joint modelling of a binary and a continuous outcome measured at two cycles to determine the optimal dose |
journalArticle |
2018 |
Ezzalfani, Monia; Burzykowski, Tomasz; Paoletti, Xavier |
[The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB] |
journalArticle |
2015 |
Ezzalfani, M.; Dugue, A.; Mollevi, C.; Pulido, M.; Bonnetain, F.; Filleron, T.; Gal, J.; Gauthier, M.; Le Deley, M. C.; Le Tourneau, C.; Medioni, J.; Nguyen, J. M.; Chabaud, S.; Teixeira, L.; Thivat, E.; You, B.; Kramar, A.; Paoletti, X. |
Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates |
journalArticle |
2018 |
Espin, J.; Schlander, M.; Godman, B.; Anderson, P.; Mestre-Ferrandiz, J.; Borget, I.; Hutchings, A.; Flostrand, S.; Parnaby, A.; Jommi, C. |
Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer |
journalArticle |
2019 |
Elhammali, A.; Blanchard, P.; Yoder, A.; Liao, Z.; Zhang, X.; Ronald Zhu, X.; Allen, P. K.; Jeter, M.; Welsh, J.; Nguyen, Q. N. |
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials |
journalArticle |
2018 |
Early Breast Cancer Trialists' Collaborative, Group |
Bevacizumab versus anti-epidermal growth factor receptor in first-line metastatic colorectal cancer. A meta-analysis: The last building block? |
journalArticle |
2016 |
Ducreux, M.; Pignon, J. P. |
Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma |
journalArticle |
2019 |
Du, C.; Blanchard, P.; Even, C.; Boros, A.; Gorphe, P.; Breuskin, I.; Baste-Rotllan, N.; Nguyen, F.; Ruffier, A.; Bidault, F.; Billard, C.; Janot, F.; Mirghani, H.; Temam, S.; Tao, Y. |
A benchmark study of scoring methods for non-coding mutations |
journalArticle |
2018 |
Drubay, D.; Gautheret, D.; Michiels, S. |
Mortality from Circulatory System Diseases among French Uranium Miners: A Nested Case-Control Study |
journalArticle |
2015 |
Drubay, D.; Caer-Lorho, S.; Laroche, P.; Laurier, D.; Rage, E. |
Mortality from Circulatory System Diseases among French Uranium Miners: A Nested Case-Control Study |
journalArticle |
2015 |
Drubay, D.; Caer-Lorho, S.; Laroche, P.; Laurier, D.; Rage, E. |
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials |
journalArticle |
2015 |
Dowsett, M.; Forbes, J. F.; Bradley, R.; Ingle, J.; Aihara, T.; Bliss, J.; Boccardo, F.; Coates, A.; Coombes, R. C.; Cuzick, J.; Dubsky, P.; Gnant, M.; Kaufmann, M.; Kilburn, L.; Perrone, F.; Rea, D.; Thürlimann, B.; van de Velde, C.; Pan, H.; Peto, R.; Davies, C.; Gray, R. |
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials |
journalArticle |
2015 |
Doussau, A.; Thiebaut, R.; Geoerger, B.; Schoffski, P.; Floquet, A.; Le Deley, M. C.; Mathoulin-Pelissier, S.; Rizzo, E.; Fumoleau, P.; Le Tourneau, C.; Paoletti, X. |
Innovations for phase I dose-finding designs in pediatric oncology clinical trials |
journalArticle |
2016 |
Doussau, A.; Geoerger, B.; Jimenez, I.; Paoletti, X. |
Innovations for phase I dose-finding designs in pediatric oncology clinical trials |
journalArticle |
2016 |
Doussau, A.; Geoerger, B.; Jimenez, I.; Paoletti, X. |
Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed-unexposed study evaluating the clinical impact of the order of drug administration |
journalArticle |
2016 |
Dourthe, M. E.; Ternes, N.; Gajda, D.; Paci, A.; Dufour, C.; Benhamou, E.; Valteau-Couanet, D. |
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival |
journalArticle |
2015 |
dos Santos, M. A.; Pignon, J. P.; Blanchard, P.; Lefeuvre, D.; Levy, A.; Touat, M.; Louvel, G.; Dhermain, F.; Soria, J. C.; Deutsch, E.; Le Teuff, G. |
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival |
journalArticle |
2015 |
dos Santos, M. A.; Pignon, J. P.; Blanchard, P.; Lefeuvre, D.; Levy, A.; Touat, M.; Louvel, G.; Dhermain, F.; Soria, J. C.; Deutsch, E.; Le Teuff, G. |
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma |
journalArticle |
2015 |
Diouf, M.; Bonnetain, F.; Barbare, J. C.; Bouche, O.; Dahan, L.; Paoletti, X.; Filleron, T. |
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma |
journalArticle |
2015 |
Diouf, M.; Bonnetain, F.; Barbare, J. C.; Bouche, O.; Dahan, L.; Paoletti, X.; Filleron, T. |
Primary cutaneous and subcutaneous Ewing sarcoma |
journalArticle |
2015 |
Di Giannatale, A.; Frezza, A. M.; Le Deley, M. C.; Marec-Bérard, P.; Benson, C.; Blay, J. Y.; Bui, B.; Judson, I.; Oberlin, O.; Whelan, J.; Gaspar, N. |